IFNG and Cryptococcal meningitis: The therapeutic potential of IFNγ to treat HIV coinfections was supported by two Phase II trials, evaluating adjunctive IFNγ to improve treatment response to antifungals in HIV patients with cryptococcal meningitis (80, 81).